|
|
| |
|
| |
But although current contraceptives such as pills and condoms are widely used, the market remains somewhat immature – demonstrating an unmet need, considering that there is no device currently available that is acceptable to everyone under every circumstance. Despite the fact that 228 million women worldwide are still at risk of an unwanted pregnancy, regulatory, political, legal, financial and social factors keep research and development for new contraceptives at all but a standstill.
For both pill and condom purchases in the US, branding and the marketing schemes and product reliability, which support the brand, remain key to purchase preference. The big difference in consumer purchasing is that condoms are readily available at gas stations, grocery stores and bars nationwide, while contraception requires a prescription from a physician.
According to the Alan Guttenmacher Institute, a not-for-profit specializing in reproductive health, 64% of more than 60 million American women of reproductive age (15-44) practice some form of contraception. Sixty-one percent of those using contraception rely on oral pills or condoms. Eighty percent of American women will rely on birth control pills at one time or another in their lives.
Very few scientific inventions have impacted society as concretely as the contraceptive pill or been linked to as many provocative incidents as the women's movement or the wild, free love times of the 1960s. Forty years after oral birth control became widely available, more than 100 million worldwide use it. According to a recent Johns Hopkins report, the Pill is the most popular contraceptive outside of China and India.
For modern consumers, a plethora of brands and a lack of scientific know-how that could best determine which Pill is most appropriate, means individuals can be in a dilemma when selecting a brand. As always, consumer satisfaction is key. Problematic, considering a new survey by the National Women's Health Resource Center (NWHRC), which reveals that half of American women who used birth control pills in the past five years were dissatisfied enough to switch brands.
Surprisingly enough, it is the side effects that rule oral contraceptive market branding. The current hit on the US market is Yasmin, by Berlex Laboratories Inc., which studies have purportedly shown not only functions as a dependable birth control method, but can also clean up acne and cause weight loss. Yasmin was approved as a contraceptive in May by the US Food and Drug Administration (FDA).
"These sort of added advantages are what give brands an edge," says Dr. Patricia J. Sulak, Scott & White Memorial Hospital's Department of Obstetrics and Gynecology, Texas A&M University Health Science Center. "There is a great need for additional oral contraceptive choices which work to not only prevent pregnancies, but ease women's pain and discomforts experienced during menstruation."
Essentially Pill brand satisfaction comes down to women feeling good about their birth control, and consumer satisfaction with present choices is low. It is therefore not surprising that the same NWHRC study reports that despite a heavy reliance upon the Pill, 700,000 unintended pregnancies occur in the US because women stop taking their oral contraceptives.
|
| |
|
And who can blame women for dissatisfaction with a product whose other side effects include nausea/vomiting, bloating/swelling, headaches and mood changes on a monthly basis?
According to Sulak, the new hit wonder will be Seasonale, which will reduce women's menstrual cycle from 13 to a mere four per year. "It's really just a repackaging of what doctors have been doing for years." Instead of working on a monthly cycle of pills, Seasonale, set to launch on the market in 2002/2003, should be taken on a three-month cycle, eliminating menstruation to once per season. Seasonale is currently under clinical trials at the Jones Institute for Reproductive Medicine at Eastern Virginia Medical School.
Although branding is slightly skewed by the prescription process, hype for groundbreaking products such as Yasmin and Seasonale tends to rope consumers in.
However, as useful as the Pill may be, it does not protect against sexually transmitted disease (STD). Condoms are actually the only dual device that are effective in reducing both pregnancy and STDs. Condoms are also the only non-surgical method of male contraception marketed throughout the world, and they are recognized as highly effective against the sexual transmission of HIV/AIDS. Nevertheless, condoms are underutilized compared with oral contraceptives and, for many consumers, are an unacceptable option.
Following the publicity surrounding the emergence of HIV/AIDS in the 1980s, the condom market and distribution channels have grown, causing a continued rise in sales volumes. Worldwide, UNFPA's condom support doubled from 1992 to 1997 and expenditures are forecasted to increase.
Despite the condom’s recent rise in popularity, it’s nothing new; the first condom dates back to 100 AD. A 1200 to 1500 year-old painting in France depicts a man using a condom during sexual intercourse and condoms were widely used against syphilis in the 1500s.
Like the Pill, condoms get a bad rap. Although physical side effects are minimal if at all, using condoms as contraception means interrupting sexual play and consumers complain of a desensitization of pleasure. And since pleasure, or specifically, safe pleasure, is the objective in sex, branding should thrive around it.
Sex, however, is a new marketing scheme for the "erection apparel" market. Throughout the 1980s and 90s, condom producers relied on staid and true "safe sex" messages like the one used by Condomi, a large European manufacturer: Be safe and have fun. A Trojan print ad from 1996 highlighted safety as well: You wouldn’t jump out of the plane without one.
While the safe sex public advocacy got the ball rolling for the condom market, sales, along with public discomfort with buying condoms remained a liability. The evolution of the normalization of condoms entailed putting safe sex branding on the back seat and the spotlight back on the product focus: sexual pleasure.
Carter-Wallace, Inc., which produces Trojan, controls more than 65% of the US condom market. Branding for Trojan focuses on sensation with products named "Ultra Pleasure," "Very Sensitive" and "Ultra Thin."
London International Group, which produces Durex condoms, controls about 20% of the condom market worldwide and the company bills itself as the number one condom manufacturer. Durex also plays up pleasure with product names like "Ultimate Feeling," "Ultra Comfort" and "High Sensation." Further to the sex focus in marketing for condoms, Durex claims its ad campaigns, which target men and women, led to a 35% increase in sales to women.
Until radical changes occur in the contraception industry, couples will just have to keep doing it with few changes in their brands and methods of contraceptives.
But for the manufacturers, developing a solution with the functional aspects to improve current methods of contraception and STD prevention is only half the battle. The real success will be in selling that new product to the individual. For that, we recommend a return to the bedroom for a more emotional approach, appealing directly to the consumer’s desire. [28-Jan-2002]
|
|
|
| |
|
| |
Katherine Daniel is a former United Nations Population Fund (UNFPA) China Programme Officer.
|
| |
|
|
|
|
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Aug 26, 2002
|
Commodities: Branding the Basics -- Eric Mirabel
|
|
|
How do we go about turning a commodity product or production capability into a new brand? We look at the Middle East, a transitioning market where manufacturers are branding commodities.
|
|
|
|
|
| |
|
Aug 19, 2002
|
Brands in Toyland -- Ron Irwin
|
|
|
Is branding in the toy world just child’s play? We look at how traditional brands like LEGO and Brio stand up to the dazzlingly high-tech competition.
|
|
|
|
|
| |
|
Aug 12, 2002
|
Long Live the King -- John Karolefski
|
|
|
Young and svelte, bloated and strung out, Elvis had universal appeal throughout his short lifespan. The king may be dead but apparently the brand lives on.
|
|
|
|
|
| |
|
Aug 5, 2002
|
IBM Navigates the Biotech Maze -- Edwin Colyer
|
|
|
IBM Global Services is expanding to a variety of areas like its recent acquisition of PwC Consulting. We look at how a brand like this penetrates the life sciences market.
|
|
|
|
|
| |
|
Jul 29, 2002
|
Do Nonprofits Have Value? -- Robin Rusch
|
|
|
As we unveil Interbrand's league tables of the world's most valuable brands for for-profit brands in 2002, we ask, Is there value in a nonprofit brand?
|
|
|
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
Copyright © 2001-2013 brandchannel. All rights reserved.
|
|